Your browser doesn't support javascript.
loading
Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis.
Bousquet, J; Anto, J M; Wickman, M; Keil, T; Valenta, R; Haahtela, T; Lodrup Carlsen, K; van Hage, M; Akdis, C; Bachert, C; Akdis, M; Auffray, C; Annesi-Maesano, I; Bindslev-Jensen, C; Cambon-Thomsen, A; Carlsen, K H; Chatzi, L; Forastiere, F; Garcia-Aymerich, J; Gehrig, U; Guerra, S; Heinrich, J; Koppelman, G H; Kowalski, M L; Lambrecht, B; Lupinek, C; Maier, D; Melén, E; Momas, I; Palkonen, S; Pinart, M; Postma, D; Siroux, V; Smit, H A; Sunyer, J; Wright, J; Zuberbier, T; Arshad, S H; Nadif, R; Thijs, C; Andersson, N; Asarnoj, A; Ballardini, N; Ballereau, S; Bedbrook, A; Benet, M; Bergstrom, A; Brunekreef, B; Burte, E; Calderon, M.
Afiliação
  • Bousquet J; University Hospital, Montpellier, France.
  • Anto JM; MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Paris, France.
  • Wickman M; INSERM, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, U1168, Paris, France.
  • Keil T; UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Versailles, France.
  • Valenta R; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Haahtela T; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
  • Lodrup Carlsen K; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • van Hage M; Department of Experimental and Health Sciences, University of Pompeu Fabra (UPF), Barcelona, Spain.
  • Akdis C; Sachs' Children's Hospital, Stockholm, Sweden.
  • Bachert C; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Akdis M; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Auffray C; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
  • Annesi-Maesano I; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Bindslev-Jensen C; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Cambon-Thomsen A; Department of Paediatrics, Oslo University Hospital, Oslo, Norway.
  • Carlsen KH; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Chatzi L; Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Forastiere F; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Garcia-Aymerich J; ENT Department, Ghent University Hospital, Gent, Belgium.
  • Gehrig U; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Guerra S; European Institute for Systems Biology and Medicine, Lyon, France.
  • Heinrich J; EPAR U707 INSERM, Paris, France.
  • Koppelman GH; EPAR UMR-S UPMC, Paris VI, Paris, France.
  • Kowalski ML; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • Lambrecht B; UMR Inserm U1027, Université de Toulouse III Paul Sabatier, Toulouse, France.
  • Lupinek C; Department of Paediatrics, Oslo University Hospital, Oslo, Norway.
  • Maier D; University of Oslo, Oslo, Norway.
  • Melén E; Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.
  • Momas I; Department of Epidemiology, Regional Health Service Lazio Region, Rome, Italy.
  • Palkonen S; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Pinart M; Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
  • Postma D; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Siroux V; Department of Experimental and Health Sciences, University of Pompeu Fabra (UPF), Barcelona, Spain.
  • Smit HA; Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • Sunyer J; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Wright J; Institute of Epidemiology, German Research Centre for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany.
  • Zuberbier T; Department of Pediatric Pulmonology and Pediatric Allergology, GRIAC Research Institute, University Medical Center Groningen, Beatrix Children's Hospital, University of Groningen, Groningen, the Netherlands.
  • Arshad SH; Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland.
  • Nadif R; VIB Inflammation Research Center, Ghent University, Ghent, Belgium.
  • Thijs C; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Andersson N; Biomay AG, Wien, Austria.
  • Asarnoj A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ballardini N; Department of Public Health and Biostatistics, EA 4064, Paris Descartes University, Paris, France.
  • Ballereau S; Paris Municipal Department of Social Action, Childhood, and Health, Paris, France.
  • Bedbrook A; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Benet M; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Bergstrom A; Department of Respiratory Medicine, GRIAC Research Institute, University Medical Center Groningen, Beatrix Children's Hospital, University of Groningen, Groningen, the Netherlands.
  • Brunekreef B; Inserm, U823, Grenoble, France.
  • Burte E; Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • Calderon M; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Allergy ; 70(9): 1062-78, 2015 Sep.
Article em En | MEDLINE | ID: mdl-25913421
ABSTRACT
Allergic diseases [asthma, rhinitis and atopic dermatitis (AD)] are complex. They are associated with allergen-specific IgE and nonallergic mechanisms that may coexist in the same patient. In addition, these diseases tend to cluster and patients present concomitant or consecutive diseases (multimorbidity). IgE sensitization should be considered as a quantitative trait. Important clinical and immunological differences exist between mono- and polysensitized subjects. Multimorbidities of allergic diseases share common causal mechanisms that are only partly IgE-mediated. Persistence of allergic diseases over time is associated with multimorbidity and/or IgE polysensitization. The importance of the family history of allergy may decrease with age. This review puts forward the hypothesis that allergic multimorbidities and IgE polysensitization are associated and related to the persistence or re-occurrence of foetal type 2 signalling. Asthma, rhinitis and AD are manifestations of a common systemic immune imbalance (mesodermal origin) with specific patterns of remodelling (ectodermal or endodermal origin). This study proposes a new classification of IgE-mediated allergic diseases that allows the definition of novel phenotypes to (i) better understand genetic and epigenetic mechanisms, (ii) better stratify allergic preschool children for prognosis and (iii) propose novel strategies of treatment and prevention.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Alérgenos / Transdução de Sinais / Hipersensibilidade Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Allergy Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Alérgenos / Transdução de Sinais / Hipersensibilidade Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Allergy Ano de publicação: 2015 Tipo de documento: Article